Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bayer Kogenate FS Supply To Reach 80% Of 2000 Factor VIII Levels By 2002

Executive Summary

Bayer expects Kogenate FS recombinant factor VIII supply in 2002 to be approximately 80% of levels in 2000, and to exceed previous quantities by 2003, Bayer board member Frank Morich, MD, told analysts.
Advertisement

Related Content

Bayer May Cut U.S. Sales Force After Cipro Generics Enter Market
Bayer May Cut U.S. Sales Force After Cipro Generics Enter Market
Wyeth To File Refacto AF Second Quarter; Will Launch End Supply Problems?
Wyeth To File Refacto AF Second Quarter; Will Launch End Supply Problems?
Bayer Kogenate supply
Bayer Kogenate supply
Bayer Finds Partial Pharma Partner In Aventis Blood Products Joint Venture
Bayer Seeking Smaller Pharma Partner; Will Retain Majority Share In Deal
Bayer Changes Pharma Leadership On Eve Of U.S. Stock Listing
Baycol Withdrawal Gives Boost To Pravachol; Will Crestor NDA Be Affected?
Advertisement
UsernamePublicRestriction

Register

PS038362

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel